Haw Par Corporation Limited (HAWPF) Research

Haw Par Corporation Limited, a company established in 1969 and headquartered in Singapore, conducts a broad range of operations including the manufacturing, marketing, and distribution of healthcare products across Singapore, ASEAN countries, other parts of Asia, and international markets. Its business activities are structured into three main segments: 1. Healthcare: This division primarily focuses on the creation and worldwide distribution of topical analgesic solutions, notably recognized for its popular Tiger Balm and Kwan Loong brands. 2. Investments: This segment is engaged in capital market activities, specifically investing in publicly traded securities. Additionally, it possesses and leases out a significant portfolio of investment properties, which includes 45,324 square meters of commercial and industrial space located in Singapore and Malaysia. 3. Others: This segment delivers leisure and entertainment experiences, prominently featuring oceanariums designed for families and tourists. Beyond these core segments, Haw Par Corporation Limited also offers property leasing services for land, buildings, and office facilities, along with providing management support services.

Market snapshot

Symbol
HAWPF
Price
$12.00
Day change
0.00%
Market cap
$3.6B
P/E ratio
13.43x
52-week range
9.4-14.17
Sector
Healthcare
Industry
Drug Manufacturers - General

Peer companies

  • Alfresa Holdings Corporation (ALFRY)
  • Aspen Pharmacare Holdings Limited (APNHY)
  • China Medical System Holdings Limited (CHSYF)
  • Curaleaf Holdings, Inc. (CURLF)
  • Dermapharm Holding SE (DMPHF)
  • HUTCHMED (China) Limited (HMDCF)
  • Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
  • Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

Open Haw Par Corporation Limited (HAWPF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.